(Corrects headline, paragraph 1 to say mid-stage study, not a late-stage study)
Dec 5 (Reuters) - Replimune Group said on Tuesday its experimental drug to treat a common form of skin cancer did not meet the main goals in a mid-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Arun Koyyur)
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
Nancy Pelosi's husband Paul Pelosi uses an investing strategy that lowers upfront costs.
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
If you have inherited retirement assets, have a Roth 401(k) or want to give retirement money to charity, you may be impacted by tweaks to this year’s rules for RMDs.
“When she died, we were told by her attorney that we were responsible for the taxes and property insurance during the time when the life tennant lives in the home.”
Here's what could happen next to Alphabet shares.
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
The $50 million purchase could turn into Nvidia's biggest investment.
The number probably isn't anywhere near what you think it is.